The CONNECT trial reveals how CGM improves A1C and time in range in type 2 diabetes patients not using insulin. Explore the findings and implications.
Read More »Three Subtypes, One Diagnosis: Scientists Uncover Hidden Differences in Adult Type 1 Diabetes
Researchers have identified three subtypes of adult-onset type 1 diabetes. Learn how they differ in insulin production and complication risks.
Read More »When Blood Sugar Results End Up in the Wrong Chart: The Hidden Danger for Hospital Patients
Hospital glucose monitoring errors can put patients at risk. Learn how wrong-patient results affect insulin decisions and how clinicians can prevent harm.
Read More »Pregnancy Can Accelerate Retinopathy, but the “Riskiest Trimester” May Be a Myth
Can diabetic retinopathy worsen during pregnancy? New research questions trimester-specific risks and highlights the value of personalized eye screening.
Read More »Salt and the Diabetic Kidney: Are Early Warning Signs Appearing Before Overt Damage?
Explore how higher salt intake may be linked to early kidney damage in older adults with type 2 diabetes and why kidney screening matters.
Read More »Mealtime Insulin Without the Injection: What Pediatric Inhaled Insulin Can and Can’t Do
What does INHALE-1 reveal about inhaled insulin for children with type 1 diabetes? Explore glucose control, safety, and treatment considerations.
Read More »Normal UACR, Declining Kidneys: The Blind Spot These Biomarkers May Expose
Discover how emerging kidney biomarkers may identify kidney decline in people with type 2 diabetes despite normal UACR levels.
Read More »Can Vitamin C or Exercise Distort a Glucose Reading? A Trial Takes a Closer Look
Can vitamin C or exercise affect glucose monitor accuracy? Explore findings from a randomized trial of CGM technology in adults with type 1 diabetes.
Read More »DASH for Diabetes? The New DASH4D Diet Puts the Idea to the Test
Can the DASH4D diet improve blood sugar control? Explore clinical trial findings and what they mean for people with type 2 diabetes.
Read More »The Guidelines Moved Faster Than Prescribing Did
Explore why diabetes prescribing still lags behind clinical guidelines, despite growing evidence supporting SGLT2 inhibitors and GLP-1 therapies.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.